September 16, 2020
Hyejung Won, PhD, and Jason Stein, PhD, in the UNC Department of Genetics and members of the UNC Neuroscience Center, led a genome-wide association study to find that lowered expression of a gene called DDHD2 may increase a person’s likelihood of autism.
May 27, 2020
The Division of Geriatric Medicine's Joshua Niznik, PharmD, PhD, has been named by the US Deprescribing Research Network as a 2020-2021 Junior Investigator Intensive Awardee. As part of the Network’s inaugural cohort, Dr. Niznik and fellow awardees will expand support for deprescribing research among older adults.
May 26, 2020
Jenny P. Ting, PhD, was selected as the 2020-2021 President of the American Association of Immunologists. Established in 1913, AAI has become the most prestigious association of immunologists in the world with nearly 8,000 scientists in 71 countries.
March 25, 2020
A major international collaboration co-led by UNC School of Medicine scientist Jason Stein, Ph.D., has produced the first genetic map of the cerebral cortex, identifying more than 300 genetic variants that influence cortical structure and play roles in psychiatric conditions.
March 21, 2020
Dirk Dittmer, PhD, professor of microbiology and immunology, is working with colleagues to explore how next generation sequencing can be used to help ensure accuracy in novel coronavirus diagnostics, as well as identify mutations and learn the history of the virus by sequencing its genome.
March 9, 2020
Led by UNC School of Medicine neuroscientist Hyejung Won, PhD, researchers created H-MAGMA, a computational tool that improves current technology used to link non-coding genetic variants to the genes associated with diseases through genome-wide association studies.
May 24, 2019
Adding genomic sequencing results to traditional newborn screening means a baby could potentially test positive for numerous conditions that might not develop within their lifetime. A UNC School of Medicine study proposed a method for how to responsibly determine which types of conditions to include in testing and potentially return to parents.
April 11, 2019
Hospital-wide dementia-friendly training is well underway at UNC Hospitals Hillsborough Campus, where nearly two-thirds of all staff and providers who interact with patients have completed training. UNC Health Care is the first major health care system in the state with plans to deliver hospital-wide training to multiple partnering hospitals. After the Hillsborough pilot, the training program will expand to NC Memorial Hospital in Chapel Hill, Pardee UNC Health Care in Hendersonville, and Wayne UNC Health Care in Goldsboro.
February 8, 2019
Interim results presented by UNC’s Joseph Muenzer, MD, PhD, provide preliminary evidence that in vivo genome editing occurred in a clinical trial testing a treatment for Mucopolysaccharidosis Type II (MPS II), also known as Hunter syndrome.
September 5, 2018
As part of the phase 1 clinical trial for patients with Hunter syndrome, Joseph Muenzer, MD, PhD, performed the UNC Clinical Translational and Research Center’s first-ever in vivo genome editing therapy, achieving a milestone in his own career.
July 30, 2018
UNC researcher Charles Carter, PhD, and Peter Wills, PhD, from the University of Aukland, show how genes were first translated into proteins to offer insight into a long-time scientific mystery.
June 21, 2018
UNC School of Medicine researchers, led by Brian Strahl, PhD, found surprising role for a protein called Spt6, which is crucial to the maintenance of proper messenger RNA levels in cells, a discovery that opens new research avenues and suggests a target for basic understanding, diagnosis, and treatment of human diseases.